Clinical Trial Update: Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting [Phase 2]

View source ↗

Summary

Phase 2 trial comparing dronabinol to placebo for HAART-related nausea and vomiting in HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dronabinol (Marinol) (dronabinol)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting, HIV Infections | Phase 2 | Status: COMPLETED